GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » Net Current Asset Value

AptarGroup (AptarGroup) Net Current Asset Value : $-9.04 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is AptarGroup Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

AptarGroup's net current asset value per share for the quarter that ended in Dec. 2023 was $-9.04.

The historical rank and industry rank for AptarGroup's Net Current Asset Value or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of AptarGroup was 605.42. The lowest was 605.42. And the median was 605.42.

ATR's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.88
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

AptarGroup Net Current Asset Value Historical Data

The historical data trend for AptarGroup's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup Net Current Asset Value Chart

AptarGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.96 -11.86 -12.42 -11.03 -9.04

AptarGroup Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.03 -10.83 -10.02 -9.05 -9.04

Competitive Comparison of AptarGroup's Net Current Asset Value

For the Medical Instruments & Supplies subindustry, AptarGroup's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where AptarGroup's Price-to-Net-Current-Asset-Value falls into.



AptarGroup Net Current Asset Value Calculation

AptarGroup's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1549.279-2130.592-14.474-0)/65.9
=-9.04

AptarGroup's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1549.279-2130.592-14.474-0)/65.9
=-9.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AptarGroup  (NYSE:ATR) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


AptarGroup Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of AptarGroup's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup (AptarGroup) Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.
Executives
Marc Prieur officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Monnas Giovanna Kampouri director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades director 281 SUMMIT AVENUE, SUMMIT NJ 07901
Hedi Tlili officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey officer: EVP and General Counsel 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Xiangwei Gong officer: President, Asia 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Shiela Vinczeller officer: Chief Human Resource Officer 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Julie Xing director 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Robert Kuhn officer: EVP & CFO C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Matthew L. Trerotola director 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Gael Touya officer: Segment President 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Candace S. Matthews director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Isabel Marey-semper director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014